These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 841765)

  • 1. [Results of drug therapy of metastasis of carcinoma of the kidney].
    Barsel' VA; Khaimchaev IaS
    Urol Nefrol (Mosk); 1977; (1):41-3. PubMed ID: 841765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of poorly responding tumors in the metastatic stage].
    Gremmel H; Liffers R
    Med Welt; 1980 Oct; 31(43):1554-6. PubMed ID: 7464515
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy in metastasis of kidney neoplasms].
    Matveev BM
    Urol Nefrol (Mosk); 1978; (3):67-70. PubMed ID: 664128
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
    Procopio G; Verzoni E; Gevorgyan A; Mancin M; Pusceddu S; Catena L; Platania M; Guadalupi V; Martinetti A; Bajetta E
    Oncology; 2007; 73(3-4):204-9. PubMed ID: 18418013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
    Balogh F; Romics I
    Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary carcinoma: syndromes of metastases].
    Uehlinger E
    Bibl Tuberc; 1965; 20():99-122. PubMed ID: 5877570
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
    Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].
    Mannes P; Derriks R; Moens R
    Acta Tuberc Pneumol Belg; 1971; 62(5):473-77. PubMed ID: 5172849
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatic therapy of metastatic breast cancer].
    Mussa A; Dogliotti L; Musumeci SV; Linfanti CV; Alabiso O; Festa V; Giugno G; Sandrucci S; Benedetto G
    Minerva Chir; 1980 Aug 15-31; 35(15-16):1195-225. PubMed ID: 7005745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The necropsy findings in carcinoma of the bronchus.
    Line DH; Deeley TJ
    Br J Dis Chest; 1971 Oct; 65(4):238-42. PubMed ID: 4944570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
    Clavel B
    Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases].
    Berndt G; Eckel H; Notter G; St Stender H
    Strahlentherapie; 1971 May; 141(5):540-8. PubMed ID: 5088730
    [No Abstract]   [Full Text] [Related]  

  • 15. [The results of a clinical study of asafan].
    Karev NI; Lichinitser MR; Moroz LV; Astrakhan VI; Beroeva GV; Blokhina NG; Buk IM
    Vopr Onkol; 1970 May; 16(5):41-5. PubMed ID: 5450810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hepatic metastases from colorectal carcinoma].
    Chiampo L; Paolucci R
    Chir Patol Sper; 1974 Jun; 22(3):173-93. PubMed ID: 4434790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastasis of various histological forms of lung cancer].
    Iagubov AS
    Arkh Patol; 1969; 31(7):28-32. PubMed ID: 5363966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metastasis in different morphologic forms of lung cancer].
    Iagubov AS
    Vopr Onkol; 1970; 16(10):24-8. PubMed ID: 5516739
    [No Abstract]   [Full Text] [Related]  

  • 19. A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma.
    Srinivas S; Guardino AE
    BJU Int; 2005 Sep; 96(4):536-9. PubMed ID: 16104906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
    Miwa S; Mizokami A; Konaka H; Izumi K; Nohara T; Namiki M
    Jpn J Clin Oncol; 2009 Nov; 39(11):745-50. PubMed ID: 19808839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.